Journal of Enzyme Inhibition and Medicinal Chemistry
Butyric acid and trichostatin A (TSA) are anti-cancer compounds that cause the upregulation of genes involved in differentiation and cell cycle regulation by inhibiting histone deacetylase (HDAC) activity. In this study we have synthesized and evaluated compounds that combine the bioavailability of short-chain fatty acids, like butyric acid, with the bidentate binding ability of TSA. A series of analogs were made to examine the effects of chain length, simple aromatic cap groups, and substituted hydroxamates on the compounds' ability to inhibit rat-liver HDAC using a fluorometric assay. In keeping with previous structure-activity relationships, the most effective inhibitors consisted of longer chains and hydroxamic acid groups. It was found that 5-phenylvaleric hydroxamic acid and 4-benzoylbutyric hydroxamic acid were the most potent inhibitors with IC50's of 5 microM and 133 microM respectively.
Taylor & Francis
Tischler, Jessica L.; Abuaita, Basel; Cuthpert, Sierra C.; Fage, Christopher; Murphy, Kristi; Saxe, Andrew; Furr, Edward B.; Hedrick, Jamie; Meyers, Jennifer; Snare, David; and Zand, Ali R., "Simple inhibitors of histone deacetylase activity that combine features of short-chain fatty acid and hydroxamic acid inhibitors" (2008). Chemistry & Biochemistry Publications. 102.